Mapping the human mucosal immune response to respiratory viruses

Mapping the human mucosal immune response
to respiratory viruses

Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.

In a study recently published in eLife, Sindhu Vangeti, PhD, and colleagues at the Icahn School of Medicine at Mount Sinai, demonstrated that innate immune cells, like monocytes and dendritic cells, possess unique dynamics defined by location and pathogen. In addition to characterizing immune cells in blood, the team also investigated immune cell distribution and function in the human nasopharynx.

Learn about:

  • Monocytes and dendritic cells in human respiratory viral infections.
  • Studying immune responses in the human airways.
  • Integrating state-of-the-art platforms into conventional study design.

Image of Sindhu Vangeti

Sindhu Vangeti, PhD

Sindhu Vangeti, PhD, is a postdoctoral fellow in Irene Ramos’s viral immunology team in the Stuart C. Sealfon lab at the Icahn School of Medicine at Mount Sinai. Currently, her research focuses on mapping the epigenetic fingerprint of influenza/SARS-CoV-2 exposure and studying mechanisms that lead to durability of vaccine-induced immunity. Dr. Vangeti obtained her doctorate in 2019 at the Karolinska Institutet in the lab of Anna Smed Sörensen, studying human immune responses to influenza and hantavirus infections.

Mapping the human mucosal immune response to respiratory viruses

A presentation by Sindhu Vangeti, PhD

More resources for immunology research

What can proteomics teach us about infectious disease?

Watch webinar

Tech Note:
SomaScan Assay v4.1 signaling in mouse plasma

Download

Case studies:
Massive-scale proteomics for COVID-19

Learn more

White paper:
COVID-19 and the SomaScan® Platform

Download

Search our publications viewer

Search our extensive database of peer-reviewed research on the use of the SomaScan® Platform by entering keywords to narrow your search, such as influenza, COVID, or respiratory.

See publications

Share with colleagues

More webinars

WebinarIdentifying Biomarkers for IBD Diagnosis and Management 

In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.

Learn more

WebinarBoutique Webinar : Predicting Pregnancy Complications with High-Plex Proteomics

The interdisciplinary team, comprising 10-15 scientists and clinician-scientists, is dedicated to advancing diagnostics and therapeutics aimed at enhancing maternal and fetal care. Their primary focus lies in the development of interventions for conditions such as ectopic pregnancy and preeclampsia, alongside the creation of diagnostics to prevent stillbirth.

Learn more

WebinarYoung blood for old brains and the quest to slow brain aging

Aging leads to the degradation of function in nearly all tissues and organs. This process is marked by significant shifts in gene expression and changes in concentrations of all types of biological molecules. Recent technological progress has allowed biologists to measure an unprecedented number of these molecules throughout an organism

Learn more

Explore webinars in our interactive viewer